Chemaphor Inc.

Chemaphor Inc.

June 22, 2009 09:00 ET

Chemaphor Announces Agreement With Allied Biotech Corporation

OTTAWA, CANADA--(Marketwire - June 22, 2009) - Chemaphor Inc. (TSX VENTURE:CFR) a biotechnology research and development company, is pleased to announce it has entered into a strategic relationship with the Allied Biotech Corporation of Taiwan. With this, Chemaphor has signed a Manufacturing Development Agreement with Allied Biotech for the development, manufacture and exclusive five year supply of Chemaphor's OxBC compound. Dr. Paul Dick, CEO of Chemaphor, said "We are very pleased to have achieved this very important milestone on the path towards the commercialization of OxBC. We believe that our relationship with Allied Biotech establishes the supply framework to meet the demands for the various markets that we intend to pursue. We are delighted to have Allied Biotech Corporation as a collaborative partner. Not only do they have world class manufacturing experience in making ß-carotene and other compounds, but they also have outstanding experience in formulation technologies, which is important to us as we move forward into other projected applications of OxBC beyond the first application as a feed additive for food production animals".

Simon Chen, Director of Allied Biotech, concurs, "We are very excited with this opportunity to work with such an innovative and outstanding company like Chemaphor on the commercialization of OxBC. The Chemaphor alliance will provide Allied with new opportunities to utilize Allied's production know how and expand our businesses beyond the traditional markets. Together with Chemaphor's entrepreneurial style, we believe that a perfect match has been created to realize the successful commercialization of OxBC and further market entrances beyond the first applications.

About OxBC

Chemaphor Inc., has developed a product, OxBC, comprised of a multitude of carotenoid oxidation products, that demonstrates a wealth of biological activities, including the ability to enhance the immune system of animals. As an immune modulator that can prime the innate immune system to more rapidly and effectively respond to incipient microbial infections, OxBC offers exciting opportunities in the field of non-antibiotic products for enhancing growth and feed efficiency of animals used in food production. OxBC is a new type of a natural health product that by helping animals maintain optimal immune function and health is expected to address the growing world-wide need for alternatives to antibiotics for promoting productivity and helping reduce disease in multiple sectors of the livestock agriculture industry.

About Chemaphor Inc.

Chemaphor Inc. ( uses its core expertise in organic chemistry to develop premium products for the animal health, skin care cosmetics, pharmaceutical and specialty chemical markets. The Company's focus is on two proprietary products, a non pharmaceutical product OxBC and a lead cancer drug compound OCL-1. Chemaphor's goal is to fully exploit its proprietary platform of carotenoid oxidation compounds by finding recognized partners to commercialize its products in multiple, large markets.

About Allied Biotech Corporation

In January 2002 Allied Biotech Corporation was formed as a subsidiary of Allied Industrial Corp., Ltd Group, with the purpose of focusing entirely on the carotenoid business. Earlier, in 2000 and 2001 Allied successfully launched its Beta-carotene products to the global food and supplement industries under the brand name Altratene®, providing an alternative choice in the market. Today Allied Biotech Corporation has become one of the worlds leading manufacturers and suppliers of carotenoids.

The Altratene® products are manufactured in a new large scale, and state-of-the-art facility in Taiwan and are animal-, BSE- and GMO-free. Additionally, they are Kosher and Halal certified and the facility holds all appropriate certifications ie. ISO9001:2000, ISO22000 and HACCP issued by SGS United Kingdom Ltd..

The product portfolio includes formulations such as oily suspensions and solutions, cold water dispersible powders and emulsions for food, feed and dietary supplement applications. Allied strives to be known as "The Carotenoid Company", as it is the only company, which is solely focusing on bringing innovative formulations of carotenoids to the market.

You can learn more about Allied on

Forward-looking statements

This news release contains forward-looking information. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of Chemaphor Inc. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Chemaphor Inc. does not assume any obligation to update or revise them to reflect new events or circumstances. (Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release)

Contact Information